Login
Home / SHTDY : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Sinopharm Group Co. Ltd.

$9.69 -$2.93 (-23.22%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$9.79
Day Range
$9.55$9.75
Year Range
$9.54$14.87
Market Cap
6.05B
AVG Volume
126.73K
Trailing/Forward PE
5.84/-
PEG ratio
0.96
Dividend Yield
5.14%
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (CNY)
0100B200B300B400B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Net Income (CNY)
02B4B6B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Operating Income (CNY)
05B10B15B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
EBITDA (CNY)
05B10B15B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Cash Flows (CNY)
-50B050B100B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
EPS (CNY)
0246821 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Expenses (CNY)
05B10B15BR&DSG&ACapex21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Cash & Debt (CNY)
025B50B75B100BCashLong Term DebtShort Term Debt21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Debt ratios
00.511.5221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Margins
0%5%10%15%20%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Return on Capital
0%2%4%6%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Shares Outstanding
0200M400M600M800M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Dividends (CNY)
00.20.40.6Jun 17Jul 18Jul 19Jun 20Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26
Book Value Per Share (CNY)
010020030021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Total Assets (CNY)
0200B400B600B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
PE Ratio
2.533.544.5med 3.34Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Free Cash Flow Yield
30%40%50%60%70%med 46.26%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
0.030.040.050.060.07med 0.05Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EV/EBITDA
1.522.53med 2.32Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price/Operating Cashflow
1.251.51.7522.25med 1.8Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Book
0.30.40.50.6med 0.43Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Sinopharm Group Co. Ltd.
SHTDY
Stockpicker

Video analysis: SHTDY

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: SHTDY

Sinopharm Group (OTCMKTS:SHTDY) and Pediatrix Medical Group (NYSE:MD) Financial Survey

defenseworld.net · 4 Sep 2026

Sinopharm Group (OTCMKTS:SHTDY) and Pediatrix Medical Group (NYSE:MD) Financial Survey

Sinopharm Group (OTCMKTS:SHTDY - Get Free Report) and Pediatrix Medical Group (NYSE: MD - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability. Analyst Recommendations This is a breakdown of

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.